Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
879
Total Claims
$79K
Drug Cost
165
Beneficiaries
$481
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-88%
Cost per patient vs peers
$481 vs $4,034 avg
-42%
Brand preference vs peers
5.5% vs 9.4% avg
Brand vs Generic
Brand: 48 claims · $39K
Generic: 831 claims · $40K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivastigmine | 47 | $17K |
| Memantine Hcl | 61 | $8,798 |
| Donepezil Hcl | 284 | $5,410 |
| Memantine Hcl | 77 | $3,600 |
| Rivastigmine Tartrate | 31 | $3,166 |
| Carbidopa/Levodopa | 17 | $1,533 |
| Venlafaxine Hcl | 51 | $1,380 |
| Buspirone Hcl | 24 | $843 |
| Mirtazapine | 21 | $457 |
| Clonazepam | 38 | $446 |
| Carbidopa/Levodopa | 21 | $435 |
| Levetiracetam | 12 | $324 |
| Escitalopram Oxalate | 21 | $320 |
| Sertraline Hcl | 15 | $288 |
| Trazodone Hcl | 22 | $274 |
Prescribing Profile
15
Unique Drugs
5.0
Anomaly Score
Patient Profile
76
Avg Age
52%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About